Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Increased risk for neonatal morbidity linked to prenatal SSRI exposure

Posted in SSRI Birth Defects

In October, 2012, a team of Swedish researchers (University of Lund) led by B. Källén published an article in Journal of Clinical Psychopharmacology titled “Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy.”, exploring the range of neonatal complications linked to prenatal exposure to selective serotonin reuptake inhibitor drugs (SSRIs).  To-date, a number of studies have clearly demonstrated that neurological birth defects, heart defects, and poor birth outcomes are linked to gestational Prozac, Paxil, and Zoloft, and other similar drugs.

This team writes “Drugs acting on the central nervous system (CNS) and given to a pregnant woman during the latter part of pregnancy may affect neonatal morbidity of the infant. … The redeeming of prescriptions for CNS-active drugs during the second or third trimester of pregnancy was studied by linkage between a register of prescribed drugs and the Swedish Medical Birth Register for the deliveries during 2006-2008 (n = 15,045 live-born infants).”

Among these children, “Neonatal morbidity was defined as the presence of neonatal diagnoses of respiratory problems, hypoglycemia, convulsions, or other CNS pathologic abnormalities including intraventricular hemorrhage, or low 5-minute Apgar score.”

Results showed that “The risk of such neonatal morbidity after maternal use of selective serotonin reuptake inhibitors (SSRIs) with or without other CNS-active drugs were evaluated as odds ratios or risk ratios, comparing with unexposed infants or infants only exposed to SSRI drugs.”

And, “The combination of SSRIs with 1 or more other CNS-active drug groups increased the risk for neonatal morbidity.”

Due to the fact that thousands of women around the world have used SSRIs unaware of the risk for increased neonatal morbidity, birth defects, and poor neonatal outcomes, SSRI birth defect lawsuits are currently being filed in great number.

If you or a loved one used SSRIs and gave birth to a child with a congenital malformation or who had perinatal complications, your family may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below.  We have the compassion, resources, and experience required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529

justinian@dangerousdrugs.us

Our SSRI Birth Defects Lawsuit Information page is a great place to start if you have any questions about SSRIs and Birth Defects.